Latest Lead News

Image Resources NL’s CEO Patrick Mutz will resign at the end of August 2026, with Chair Winston Lee stepping in as Executive Chair during the leadership transition. The company continues to operate its Atlas project while exploring innovative synthetic rutile processing.

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

Hazer Group and KBR have secured a paid pre-feasibility study with a leading Japanese power utility to explore large-scale deployment of methane pyrolysis technology, reinforcing Hazer's foothold in Japan's clean hydrogen market.

Sinclair Gold has locked in a binding earn-in agreement with Medaro Mining, unlocking up to $3.4 million in combined cash, shares, and exploration funding for its Sala silver-zinc-lead project in Sweden. Sinclair retains a net smelter return royalty and focuses on advancing its Mt Henry gold asset.

Nelson Resources has completed a comprehensive soil sampling program at its Cinnamon Property in Nevada, affirming a high-grade copper-gold discovery at Sheba and prioritising the near-surface tungsten potential at Ophir.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

Rox Resources (ASX: RXL) has reported strong underground drilling results at Youanmi’s United North area, with mineralisation extending beyond the Definitive Feasibility Study (DFS) mine plan and infrastructure contracts advancing, keeping the project on track for mid-2027 gold production.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Marlin Global delivered a robust 3.1% gross portfolio return in July 2026, significantly outpacing its benchmark which fell 3.6%, thanks to strategic semiconductor underweighting and strong gains in tech giants Microsoft, Dexcom, and Amazon.

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

Thrive Tribe Technologies has completed a small-scale capital raise, issuing 235 million shares at $0.001 each to bolster working capital. The lead manager, Clee Capital, will receive a fee and options subject to shareholder approval.